Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Johnson JR
  • MESH
  • Antitubercular Agents
  • Humans
  • Isoniazid
  • Male
  • Rifampin
  • Tuberculosis

Unbound MEDLINE

Rifapentine and isoniazid for latent tuberculosis.

Links

  • Publisher Full Text

    • Authors

    Johnson JR

    Source

    The New England journal of medicine 366:15 2012 Apr 12 pg 1447; author reply 1448

    MeSH

    Antitubercular Agents
    Humans
    Isoniazid
    Male
    Rifampin
    Tuberculosis

    Pub Type(s)

    Comment
    Letter

    Language

    eng

    PubMed ID

    22494127

    Related Citations

    • Rifapentine and isoniazid for latent tuberculosis.
    • Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    • Three months of rifapentine and isoniazid for latent tuberculosis infection.
    • Practical preventive therapy for tuberculosis?
    • A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.
    • Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.
    • Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report.
    • New approaches to the treatment of latent tuberculosis.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved